CCNDBP1 抗体
(Cyclin D-Type Binding-Protein 1 (CCNDBP1))
This gene was identified by the interaction of its gene product with Grap2, a leukocyte-specific adaptor protein important for immune cell signaling. The protein encoded by this gene was shown to interact with cyclin D. Transfection of this gene in cells was reported to reduce the phosphorylation of Rb gene product by cyclin D-dependent protein kinase, and inhibit E2F1-mediated transcription activity. This protein was also found to interact with helix-loop-helix protein E12 and is thought to be a negative regulator of liver-specific gene expression. Several alternatively spliced variants have been found for this gene. [provided by RefSeq, Apr 2009].
| Catalog no. | 产品 | 适用 | 宿主 / 克隆类型 | 应用 | 价格和交货时间 |
|---|---|---|---|---|---|
| CCNDBP1 抗体 (AA 261-360) | 人 | 小鼠 Monoclonal |
|
|
|
| CCNDBP1 抗体 (C-Term) | 人 | 兔 Polyclonal |
|
|
|
| CCNDBP1 抗体 (N-Term) | 人 | 兔 Polyclonal |
|
|
|
| CCNDBP1 抗体 (AA 1-360) | 人 | 小鼠 Polyclonal |
|
|
|
| CCNDBP1 抗体 (C-Term) | 人, Cow, 兔, Pig, Hamster, 猴 | 兔 Polyclonal |
|
|
|
| CCNDBP1 抗体 (AA 179-228) | 人, 犬, 马 | 兔 Polyclonal |
|
|
|
| CCNDBP1 抗体 | 人, 小鼠, 大鼠 | 兔 Polyclonal |
|
|
|
| CCNDBP1 抗体 (C-Term) | 人 | 山羊 Polyclonal |
|
|
|
| CCNDBP1 抗体 (AA 322-333) | 人 | 山羊 Polyclonal |
|
|
|
| CCNDBP1 抗体 (AA 281-360) | 人 | 兔 Polyclonal |
|
|
|
| CCNDBP1 抗体 (AA 281-360) (AbBy Fluor® 350) | 人 | 兔 Polyclonal |
|
|
|
| CCNDBP1 抗体 (AA 281-360) (Biotin) | 人 | 兔 Polyclonal |
|
|
|
| CCNDBP1 抗体 (AA 281-360) (Cy3) | 人 | 兔 Polyclonal |
|
|
|
| CCNDBP1 抗体 (AA 281-360) (AbBy Fluor® 647) | 人 | 兔 Polyclonal |
|
|
|
| CCNDBP1 抗体 (AA 281-360) (AbBy Fluor® 680) | 人 | 兔 Polyclonal |
|
|
|
| CCNDBP1 抗体 (AA 281-360) (AbBy Fluor® 594) | 人 | 兔 Polyclonal |
|
|
|
| CCNDBP1 抗体 (AA 281-360) (AbBy Fluor® 750) | 人 | 兔 Polyclonal |
|
|
|
| CCNDBP1 抗体 (AA 281-360) (AbBy Fluor® 555) | 人 | 兔 Polyclonal |
|
|
|
| CCNDBP1 抗体 (AA 281-360) (AbBy Fluor® 488) | 人 | 兔 Polyclonal |
|
|
|
| CCNDBP1 抗体 (AA 281-360) (HRP) | 人 | 兔 Polyclonal |
|
|
Primary Antibody
- WB (Western Blotting: 有验证图片)
- ELISA (ELISA: 有验证图片)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 3B7
- 标记
- unconjugated
- 抗体亚型
- IgG2a
- 抗原表位
- AA 261-360
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (Immunohistochemistry: 有验证图片)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- C-Term
Primary Antibody
- WB (Western Blotting: 有验证图片)
5 references - 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 克隆
- RB40537
- 标记
- unconjugated
- 抗体亚型
- Ig Fraction
- 抗原表位
- AA 21-49, N-Term
Primary Antibody
- WB (Western Blotting: 有验证图片)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗原表位
- AA 1-360
Primary Antibody
- WB (Western Blotting: 有验证图片)
- ELISA (ELISA: 所列应用)
- 适用
- 人, 小鼠, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
Primary Antibody
- IHC (Immunohistochemistry: 有验证图片)
- ELISA (ELISA: 所列应用)
- 质量等级
- Verified
- 适用
- 人
- 宿主
- 山羊
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- C-Term
Primary Antibody
- WB (Western Blotting: 有验证图片)
- ELISA (ELISA: 所列应用)
- 质量等级
- Verified
- 适用
- 人
- 宿主
- 山羊
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 322-333
Primary Antibody
- WB (Western Blotting: 所列应用)
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- IHC (fro) (Immunohistochemistry (Frozen Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 281-360
Primary Antibody
- WB (Western Blotting: 所列应用)
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- AbBy Fluor® 350
- 抗体亚型
- IgG
- 抗原表位
- AA 281-360
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- IHC (fro) (Immunohistochemistry (Frozen Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Biotin
- 抗体亚型
- IgG
- 抗原表位
- AA 281-360
Primary Antibody
- WB (Western Blotting: 所列应用)
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Cy3
- 抗体亚型
- IgG
- 抗原表位
- AA 281-360
Primary Antibody
- WB (Western Blotting: 所列应用)
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- AbBy Fluor® 647
- 抗体亚型
- IgG
- 抗原表位
- AA 281-360
Primary Antibody
- WB (Western Blotting: 所列应用)
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- AbBy Fluor® 680
- 抗体亚型
- IgG
- 抗原表位
- AA 281-360
Primary Antibody
- WB (Western Blotting: 所列应用)
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- AbBy Fluor® 594
- 抗体亚型
- IgG
- 抗原表位
- AA 281-360
Primary Antibody
- WB (Western Blotting: 所列应用)
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- AbBy Fluor® 750
- 抗体亚型
- IgG
- 抗原表位
- AA 281-360
Primary Antibody
- WB (Western Blotting: 所列应用)
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- AbBy Fluor® 555
- 抗体亚型
- IgG
- 抗原表位
- AA 281-360
Primary Antibody
- WB (Western Blotting: 所列应用)
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- AbBy Fluor® 488
- 抗体亚型
- IgG
- 抗原表位
- AA 281-360
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- IHC (fro) (Immunohistochemistry (Frozen Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- HRP
- 抗体亚型
- IgG
- 抗原表位
- AA 281-360
Latest Publications for our CCNDBP1 抗体
: "A novel senescence-evasion mechanism involving Grap2 and Cyclin D interacting protein inactivation by Ras associated with diabetes in cancer cells under doxorubicin treatment." in: Cancer research, Vol. 70, Issue 11, pp. 4357-65, (2010) (PubMed).
: "Crystallization and preliminary X-ray diffraction analysis of GCIP/HHM transcriptional regulator." in: Acta crystallographica. Section F, Structural biology and crystallization communications, Vol. 65, Issue Pt 1, pp. 21-4, (2009) (PubMed).
: "An Id-like molecule, HHM, is a synexpression group-restricted regulator of TGF-beta signalling." in: The EMBO journal, Vol. 27, Issue 22, pp. 2955-65, (2008) (PubMed).
: "Immunohistochemical expression of GCIP in breast carcinoma: relationship with tumour grade, disease-free survival, mucinous differentiation and response to chemotherapy." in: Histopathology, Vol. 53, Issue 5, pp. 554-60, (2008) (PubMed).
: "Ribosomal phosphoprotein P0 interacts with GCIP and overexpression of P0 is associated with cellular proliferation in breast and liver carcinoma cells." in: Oncogene, Vol. 27, Issue 3, pp. 332-8, (2008) (PubMed).
: "p29, a novel GCIP-interacting protein, localizes in the nucleus." in: Biochemical and biophysical research communications, Vol. 279, Issue 2, pp. 732-7, (2001) (PubMed).
: "GCIP, a novel human grap2 and cyclin D interacting protein, regulates E2F-mediated transcriptional activity." in: The Journal of biological chemistry, Vol. 275, Issue 27, pp. 20942-8, (2000) (PubMed).
: "Crystallization and preliminary X-ray diffraction analysis of GCIP/HHM transcriptional regulator." in: Acta crystallographica. Section F, Structural biology and crystallization communications, Vol. 65, Issue Pt 1, pp. 21-4, (2009) (PubMed).
: "An Id-like molecule, HHM, is a synexpression group-restricted regulator of TGF-beta signalling." in: The EMBO journal, Vol. 27, Issue 22, pp. 2955-65, (2008) (PubMed).
: "Immunohistochemical expression of GCIP in breast carcinoma: relationship with tumour grade, disease-free survival, mucinous differentiation and response to chemotherapy." in: Histopathology, Vol. 53, Issue 5, pp. 554-60, (2008) (PubMed).
: "Ribosomal phosphoprotein P0 interacts with GCIP and overexpression of P0 is associated with cellular proliferation in breast and liver carcinoma cells." in: Oncogene, Vol. 27, Issue 3, pp. 332-8, (2008) (PubMed).
: "p29, a novel GCIP-interacting protein, localizes in the nucleus." in: Biochemical and biophysical research communications, Vol. 279, Issue 2, pp. 732-7, (2001) (PubMed).
: "GCIP, a novel human grap2 and cyclin D interacting protein, regulates E2F-mediated transcriptional activity." in: The Journal of biological chemistry, Vol. 275, Issue 27, pp. 20942-8, (2000) (PubMed).
Aliases for CCNDBP1 抗体
cyclin D1 binding protein 1 (CCNDBP1) 抗体cyclin D-type binding-protein 1 (ccndbp1) 抗体
cyclin D-type binding-protein 1 (Ccndbp1) 抗体
cyclin D1 binding protein 1 (Ccndbp1) 抗体
AU022347 抗体
CCNDBP1 抗体
dip1 抗体
DIP1 抗体
gcip 抗体
GCIP 抗体
HHM 抗体
Maid 抗体
SECC-8 抗体
SSEC-8 抗体
您还需要查找其他产品吗？
You are here:
